Adjuvant Zinc May Increase the Efficacy of Botulinum Toxin

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AbbVie
AbbVieNORTH CHICAGO, IL
1 program
zinc citrate 50 mgN/A1 trial
Active Trials
NCT05894109Withdrawn0Est. Oct 2024

Trial Timeline

Clinical trial activity over time

2024
2025
2026
AbbViezinc citrate 50 mg

Clinical Trials (1)

NCT05894109AbbViezinc citrate 50 mg

Efficacy of Zinc Supplementation on Botox Treated Forehead Rhytids

Start: Aug 2024Est. completion: Oct 20240
N/AWithdrawn

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space